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LETTER TO THE EDITOR
Alcohol and cancer
Sir - The source of information cited in the Guest Editorial
by A.J. Tuyns (Br. J. Cancer, 1991, 64, 415-416) does not
support the points made about the dose-response relationship
between alcohol consumption and cancer. Some of us partici-
pated in the IARC Working Group preparing the monograph
on Alcohol Drinking and witnessed the very controversial
discussions over the conclusions; further, we are all on record
as disagreeing with IARC's qualitative conclusions about
alcohol. We disagree with Tuyns on some of his interpreta-
tions and particularly his extrapolations of the data.
The Preamble specifically states (page 27 of the Alcohol
Drinking monograph) that the Evaluations 'refer only to the
strength of the evidence that these agents are carcinogenic
and not to the extent of this carcinogenic activity (potency)
nor to the mechanism involved.' Participants in the IARC
Working Group are specifically instructed that dose must not
be considered in the evaluation; if it is carcinogenic at any
dose, then it is to be classified as a carcinogen. Tuyns'
Editorial does not reflect this constraint and even proceeds to
proclaim that 'there is a continuous risk curve - comparable
- to curves observed in laboratory animals exposed to many
other carcinogens.' The data support neither Tuyns' state-
ments nor his mathematical expressions of the additive effect
with tobacco and nutrition.
Tuyns correctly states that repeated attempts to produce
cancer in experimental animals by administration of ethanol
have failed; this is also the conclusion in the IARC mono-
graph on Alcohol Drinking. In fact, it was one reason that
the decision was made to title the monograph 'Alcohol Drin-
king' and not 'Alcohol'; nevertheless, Tuyns, in his guest
editorial, neglects this distinction and even misquotes the
IARC document to state that 'alcohol is carcinogenic to
man.'
The inability to demonstrate that ethanol is carcinogenic in
experimental animals requires that the evaluation be done
exclusively from epidemiological studies. The IARC cohort
and case-control studies, in the aggregate, found no convinc-
ing association with alcohol drinking for cancer of the
stomach, colon, pancreas, breast or lung. The data at these
sites showed either no correlation or a mixture of negative
and positive correlations. Data at other sites showed either
no association or was so sparse that an evaluation was
precluded. From these epidemiological studies the IARC
monograph concludes that the occurrence of malignant tu-
mors in only five sites, i.e., 'oral cavity, pharynx, larynx,
esophagus and liver is causally related to the consumption of
alcoholic beverages.' As Tuyns correctly points out, most of
these studies are confounded by concurrent cigarette smok-
ing. Although IARC contends that the association exists even
after adjustment for tobacco smoking, accurately adjusting
for cigarette smoking in the absence of sufficient independent
data on each factor alone is problematic at best. Therefore, it
is instructive and indeed enlightening to examine the epidem-
iological studies on nonsmokers for these five sites.
For the oral cavity and pharynx, the IARC document cites
four reports in nonsmokers. In two of these (Wynder et al.,
1957; Tuyns et al., 1988) there was no increase in cancer in
drinkers over the incidence in controls. In another study
(Rothman & Keller, 1972 or Rothman, 1976) a trend for an
increase with drinking was not significant by the Cochran-
Mantel-Armitage test. In the last study (Elwood et al., 1984),
the increase in cancer was statistically significant only at the
highest level of alcohol intake, but the incidence of cancer in
the lowest level of alcohol intake was lower than that
expected from the controls. Elwood et al. also found a
significantly increased risk with low socio-economic status,
the unmarried state and poor dental care. It is interesting
that in Tuyns' own report, the group with the lowest level of
drinking also had fewer cases than expected from their con-
trols. However, Tuyns combines nondrinkers with drinkers
consuming up to 40 grams per day of alcohol into a single
group; consequently, it is difficult to analyse his data.
Laryngeal cancer is of special interest because it is a site
which does not have direct contact with ingested alcohol. The
IARC document cites four reports of studies in nonsmokers.
The data in the Wynder et al. (1976) report show no cases of
laryngeal cancer among nonsmoking drinkers whereas there
were five cases among nonsmoking nondrinkers. Burch et al.
(1981) show a calculated estimate of an increase in risk of
laryngeal cancer in nonsmoking drinkers with increasing con-
sumption of alcohol; however, they provide no data for
nonsmoking drinkers and the degree of validity of their
calculated adjustments from smokers is unknown. The other
two studies (Elwood et al., 1984; Tuyns et al., 1988) have
already been discussed above in the paragraph on the oral
cavity and pharynx. The data of Elwood et al. were, in fact,
combined for oral cavity, pharynx and larynx. Tuyns et al.
calculated an expected 9.4 cases of cancer of the endolarynx
for their 0-40 grams/day group; however, only seven cases
were observed.
The literature on cancer of the esophagus is perhaps the
most interesting. Tuyns (1983) is the only study cited by
IARC on esophageal cancer in nonsmoking drinkers, and it
is the largest study (743 esophageal cancer patients) of any of
the five sites in nonsmokers. Tuyns makes his relative risk
(RR) calculations in this report, as in all his reports of which
we are aware, by combining the nondrinkers with drinkers of
up to 40 grams per day into his control 'nondrinker' group.
His justification apparently is that there are so few truly
nondrinkers in the populations he has studied. However, in
this report he does give raw data for nondrinkers and groups
of drinkers in increasing increments of 20 grams per day
from which calculations can be made. Several interesting
observations emerge from these calculations. Light to mod-
erate drinking males (up to 40 grams per day) showed
empirically a decreased risk of esophageal cancer (0-20
grams/day, RR = 0.48; 20-40 grams/day, RR = 0.35). This
possible protective effect is not only obscured by combining
these drinkers with nondrinkers, but it also makes his appar-
ent RR greater for heavier drinkers. The only group which is
significantly different from true nondrinkers is drinkers of
more than 120 grams/day. If all levels of drinking are com-
bined, the RR is not significantly elevated above that for
nondrinkers. If one argues that the number of cases in the
nondrinkers is so small so as to invalidate the calculation,
one may examine his data for females where the number of
nondrinkers is greater. The RR in females at all levels of
drinking combined is not elevated above that for nondrinkers
yet the nondrinker comparison group is larger than his com-
bined so-called 'nondrinker' group of males. In addition, the
RR's calculated for each group of female drinkers show the
same decreased risk in light to moderate drinkers.
The effect of dietary factors on cancer of the oral cavity,
pharynx and esophagus has been studied in several reports
(e.g. Tuyns et al., 1987; Graham et al., 1990; Gridley et al.,
1990). Foods and nutrients have been identified which
significantly increase or decrease the risk for cancer at these
sites. Among the protective substances were fresh meat,
polyunsaturated fats, carotene, fruits and vegetables; whereas
nitrite-containing meats, increased calories and fat were
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associated with an increased risk. Since the nutritional status
of heavy drinkers could very well reflect a dietary pattern
that would increase their risk to cancer at these sites, one
cannot conclude that alcohol is a carcinogen at these sites.
As Tuyns et al. (1987) state so well: 'high colinearity - limits
the possibility of using statistical procedures for controlling
for multiple confounding items; it also indicates how dan-
gerous it may be to draw conclusions based on crude
analyses.'
The decreased risk of esophageal cancer for nonsmoking
drinkers of less than 40 grams/day which may be calculated
from Tuyns' data can be noted in other reports which are
cited in the IARC document. In fact, when dose-response
data are present in reports so that one can evaluate the shape
of the dose-response curve against nondrinkers, a 'J'-shaped
dose-response curve commonly appears. Articles continue to
appear which support this observation. For example, Boffeta
and Garfinkel (1990) found decreased mortality from all
cancers for light drinkers in a very large study of US men.
Interpretation of a possible association between liver can-
cer and alcohol drinking poses problems in confounding in
addition to cigarette smoking because of the known car-
cinogenicity of some prevalent hepatitis viruses and because
of the frequency of metastatic liver cancer. Indeed, most of
the studies cited in the IARC document were noted by the
Working Group to have no data on hepatitis B virus
serology. In fact, in the largest study (Trichopoulos et al.,
1987) where most of the cases were histologically confirmed
and data on hepatitis B carrier status and cigarette smoking
were available, no association with ethanol consumption was
found after adjustment for the other factors. Furthermore,
hepatitis C virus was unknown at the time the IARC docu-
ment was prepared, and it is also strongly associated with
hepatocellular carcinoma (Hasan et al., 1990; Bruix et al.,
1989). Infection with hepatitis C virus also correlates with
heavy alcohol consumption (Yasuyama, 1991; Mendenhall et
al., 1991).
In summary, we do not think that the weight of the
evidence indicates that alcohol is a carcinogen at all. The
animal studies, despite their deficiencies in design, support
this view since a carcinogen potent enough to induce tumours
in five target sites in one species would, by current ex-
perience, be expected to produce tumours in other species as
well even with limited or intermittent periods of administra-
tion. If, indeed, there is a correlation between alcohol drink-
ing and cancer at a few sites, the shape of the dose-response
curve is most likely a 'J' shape similar to that found fre-
quently for alcohol drinking and cardiovascular disease. If
there is a correlation between heavy alcohol consumption
and cancer at some sites, there is nothing to indicate that it is
a causal association; the cause could just as likely be a
confounding covariable such as tobacco smoking, diet, poor
dental care, socio-economic status or viral infection.
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